| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of modification of synaptic structure | 4.18e-06 | 29 | 78 | 4 | GO:1905244 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CHL1 COL6A1 ERBB2 MYH9 CDH26 CYFIP1 GLI3 NTNG1 IGSF9 BAIAP2 ZDHHC17 MPIG6B ITGB3 CYFIP2 OPHN1 ARAP1 | 8.22e-06 | 1194 | 78 | 16 | GO:0000902 |
| GeneOntologyBiologicalProcess | synapse organization | ERBB2 GRIPAP1 ERBB4 CYFIP1 CHRD NTNG1 IGSF9 BAIAP2 ZDHHC17 ITGB3 CYFIP2 OPHN1 | 9.55e-06 | 685 | 78 | 12 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction organization | ERBB2 GRIPAP1 ERBB4 MYH9 CDH26 CYFIP1 CHRD NTNG1 IGSF9 BAIAP2 ZDHHC17 ITGB3 CYFIP2 OPHN1 | 1.52e-05 | 974 | 78 | 14 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of neurotrophin TRK receptor signaling pathway | 3.41e-05 | 17 | 78 | 3 | GO:0051386 | |
| GeneOntologyBiologicalProcess | cellular response to epidermal growth factor stimulus | 3.52e-05 | 49 | 78 | 4 | GO:0071364 | |
| GeneOntologyBiologicalProcess | modification of synaptic structure | 4.13e-05 | 51 | 78 | 4 | GO:0099563 | |
| GeneOntologyBiologicalProcess | response to epidermal growth factor | 5.18e-05 | 54 | 78 | 4 | GO:0070849 | |
| GeneOntologyBiologicalProcess | axonogenesis | CHL1 ERBB2 CYFIP1 GLI3 NTNG1 IGSF9 BAIAP2 ZDHHC17 CYFIP2 OPHN1 | 5.27e-05 | 566 | 78 | 10 | GO:0007409 |
| GeneOntologyBiologicalProcess | rhythmic process | 6.45e-05 | 360 | 78 | 8 | GO:0048511 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | PPARGC1A ERBB2 TRPV1 ERBB4 CYFIP1 ADAMTS7 FOS CHRD BAIAP2 ZDHHC17 ITGB3 CYFIP2 | 7.89e-05 | 850 | 78 | 12 | GO:0071363 |
| GeneOntologyBiologicalProcess | regulation of establishment of blood-brain barrier | 8.43e-05 | 4 | 78 | 2 | GO:0090210 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.02e-04 | 285 | 78 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.04e-04 | 286 | 78 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | response to growth factor | PPARGC1A ERBB2 TRPV1 ERBB4 CYFIP1 ADAMTS7 FOS CHRD BAIAP2 ZDHHC17 ITGB3 CYFIP2 | 1.13e-04 | 883 | 78 | 12 | GO:0070848 |
| GeneOntologyBiologicalProcess | ERBB2-ERBB4 signaling pathway | 1.40e-04 | 5 | 78 | 2 | GO:0038135 | |
| GeneOntologyBiologicalProcess | axon development | CHL1 ERBB2 CYFIP1 GLI3 NTNG1 IGSF9 BAIAP2 ZDHHC17 CYFIP2 OPHN1 | 1.49e-04 | 642 | 78 | 10 | GO:0061564 |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 1.88e-04 | 75 | 78 | 4 | GO:0032922 | |
| GeneOntologyBiologicalProcess | establishment of meiotic spindle localization | 2.10e-04 | 6 | 78 | 2 | GO:0051295 | |
| GeneOntologyBiologicalProcess | ammonium homeostasis | 2.10e-04 | 6 | 78 | 2 | GO:0097272 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CHL1 ERBB2 CYFIP1 GLI3 NTNG1 IGSF9 BAIAP2 ZDHHC17 ITGB3 CYFIP2 OPHN1 | 2.67e-04 | 826 | 78 | 11 | GO:0048858 |
| GeneOntologyBiologicalProcess | neurotrophin TRK receptor signaling pathway | 2.86e-04 | 34 | 78 | 3 | GO:0048011 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 3.55e-04 | 248 | 78 | 6 | GO:0007623 | |
| GeneOntologyBiologicalProcess | response to activity | 3.78e-04 | 90 | 78 | 4 | GO:0014823 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane repair | 3.90e-04 | 8 | 78 | 2 | GO:1905684 | |
| GeneOntologyBiologicalProcess | positive regulation of neurotrophin TRK receptor signaling pathway | 3.90e-04 | 8 | 78 | 2 | GO:0051388 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 3.95e-04 | 164 | 78 | 5 | GO:0099072 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | PPARGC1A MYH9 CYFIP1 CTC1 TBC1D2 NFRKB NAA80 BAIAP2 SAXO1 SIRT6 ITGB3 CYFIP2 ARAP1 KNL1 | 4.59e-04 | 1342 | 78 | 14 | GO:0033043 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CHL1 ERBB2 CYFIP1 GLI3 NTNG1 IGSF9 BAIAP2 ZDHHC17 CYFIP2 OPHN1 | 5.03e-04 | 748 | 78 | 10 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 5.60e-04 | 177 | 78 | 5 | GO:0008064 | |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 5.85e-04 | 101 | 78 | 4 | GO:0097120 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 6.04e-04 | 180 | 78 | 5 | GO:0030832 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle recycling | 6.16e-04 | 44 | 78 | 3 | GO:1903421 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 6.23e-04 | 384 | 78 | 7 | GO:0032956 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 6.48e-04 | 278 | 78 | 6 | GO:0031503 | |
| GeneOntologyBiologicalProcess | plasma membrane organization | 7.35e-04 | 188 | 78 | 5 | GO:0007009 | |
| GeneOntologyBiologicalProcess | response to dietary excess | 7.48e-04 | 47 | 78 | 3 | GO:0002021 | |
| GeneOntologyBiologicalProcess | neurotrophin signaling pathway | 7.48e-04 | 47 | 78 | 3 | GO:0038179 | |
| GeneOntologyBiologicalProcess | ERBB4 signaling pathway | 7.60e-04 | 11 | 78 | 2 | GO:0038130 | |
| MousePheno | hypochlorhydria | 3.80e-06 | 7 | 68 | 3 | MP:0008001 | |
| MousePheno | abnormal anxiety-related response | CHL1 ZNF462 PPARGC1A TRPV1 CYFIP1 ADAMTS7 LNPEP FOS TAFA3 NAB2 CHD8 CYFIP2 RAI1 OPHN1 | 1.03e-05 | 740 | 68 | 14 | MP:0001362 |
| MousePheno | abnormal blood circulation | UBR2 PPARGC1A ERBB2 TRPV1 ERBB4 CDH26 FOS GLI3 MAP3K9 CHRD BAIAP2 BIRC6 ITGB3 RECK | 4.51e-05 | 845 | 68 | 14 | MP:0002128 |
| MousePheno | abnormal learning/memory/conditioning | CHL1 TRPV1 GRIPAP1 KMT2D CYFIP1 LNPEP CYP7A1 FOS NAB2 PER1 CHRD CHD8 BAIAP2 IMMT RAI1 OPHN1 GSTA1 | 6.61e-05 | 1239 | 68 | 17 | MP:0002063 |
| MousePheno | abnormal cognition | CHL1 TRPV1 GRIPAP1 KMT2D CYFIP1 LNPEP CYP7A1 FOS NAB2 PER1 CHRD CHD8 BAIAP2 IMMT RAI1 OPHN1 GSTA1 | 7.09e-05 | 1246 | 68 | 17 | MP:0014114 |
| MousePheno | increased stomach pH | 7.13e-05 | 17 | 68 | 3 | MP:0008006 | |
| MousePheno | abnormal geniculate ganglion morphology | 8.53e-05 | 18 | 68 | 3 | MP:0001082 | |
| MousePheno | abnormal stomach pH | 1.01e-04 | 19 | 68 | 3 | MP:0008004 | |
| MousePheno | abnormal fear/anxiety-related behavior | CHL1 ZNF462 PPARGC1A TRPV1 CYFIP1 ADAMTS7 LNPEP FOS TAFA3 NAB2 CHD8 CYFIP2 RAI1 OPHN1 | 1.12e-04 | 919 | 68 | 14 | MP:0002065 |
| MousePheno | increased anxiety-related response | 1.27e-04 | 311 | 68 | 8 | MP:0001363 | |
| MousePheno | abnormal CNS synaptic transmission | TRPV1 GRIPAP1 ERBB4 CYFIP1 CTC1 SCN9A CHRD IGSF9 CHD8 MUC5B BAIAP2 ZDHHC17 CYFIP2 OPHN1 | 2.31e-04 | 985 | 68 | 14 | MP:0002206 |
| MousePheno | abnormal gastric parietal cell morphology | 2.64e-04 | 26 | 68 | 3 | MP:0004139 | |
| MousePheno | abnormal vascular development | 2.71e-04 | 542 | 68 | 10 | MP:0000259 | |
| MousePheno | hemorrhage | UBR2 ERBB2 CDH26 FOS GLI3 MAP3K9 CHRD BAIAP2 BIRC6 ITGB3 RECK | 3.31e-04 | 664 | 68 | 11 | MP:0001914 |
| MousePheno | abnormal laryngeal cartilage morphology | 3.67e-04 | 29 | 68 | 3 | MP:0002256 | |
| MousePheno | abnormal spatial learning | 3.76e-04 | 276 | 68 | 7 | MP:0001463 | |
| Domain | Cytoplasmic_FMR1-int | 1.68e-05 | 2 | 77 | 2 | IPR008081 | |
| Domain | FragX_IP | 1.68e-05 | 2 | 77 | 2 | PF05994 | |
| Domain | DUF1394 | 1.00e-04 | 4 | 77 | 2 | PF07159 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 1.00e-04 | 4 | 77 | 2 | IPR016245 | |
| Domain | DUF1394 | 1.00e-04 | 4 | 77 | 2 | IPR009828 | |
| Domain | Ammonium_transpt | 1.66e-04 | 5 | 77 | 2 | IPR001905 | |
| Domain | Ammonium_transp | 1.66e-04 | 5 | 77 | 2 | PF00909 | |
| Domain | NH4_transpt_AmtB-like_dom | 1.66e-04 | 5 | 77 | 2 | IPR024041 | |
| Domain | RhesusRHD | 1.66e-04 | 5 | 77 | 2 | IPR002229 | |
| Domain | GF_recep_IV | 2.49e-04 | 6 | 77 | 2 | PF14843 | |
| Domain | GF_recep_IV | 2.49e-04 | 6 | 77 | 2 | IPR032778 | |
| Domain | Furin-like | 3.48e-04 | 7 | 77 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 3.48e-04 | 7 | 77 | 2 | IPR000494 | |
| Domain | - | 3.48e-04 | 7 | 77 | 2 | 1.10.3430.10 | |
| Domain | Ammonium/urea_transptr | 3.48e-04 | 7 | 77 | 2 | IPR029020 | |
| Domain | Furin-like_Cys-rich_dom | 3.48e-04 | 7 | 77 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 3.48e-04 | 7 | 77 | 2 | PF01030 | |
| Domain | - | 3.48e-04 | 7 | 77 | 2 | 3.80.20.20 | |
| Domain | Znf-RING_LisH | 3.68e-04 | 34 | 77 | 3 | IPR027370 | |
| Domain | zf-RING_UBOX | 3.68e-04 | 34 | 77 | 3 | PF13445 | |
| Domain | I-BAR_dom | 1.27e-03 | 13 | 77 | 2 | IPR013606 | |
| Domain | NPIP | 1.48e-03 | 14 | 77 | 2 | IPR009443 | |
| Domain | Furin_repeat | 2.46e-03 | 18 | 77 | 2 | IPR006212 | |
| Domain | FU | 2.46e-03 | 18 | 77 | 2 | SM00261 | |
| Domain | PLAC | 2.74e-03 | 19 | 77 | 2 | PS50900 | |
| Domain | PLAC | 2.74e-03 | 19 | 77 | 2 | IPR010909 | |
| Domain | BBOX | 2.90e-03 | 69 | 77 | 3 | SM00336 | |
| Domain | - | 3.15e-03 | 71 | 77 | 3 | 4.10.45.10 | |
| Domain | zf-B_box | 3.28e-03 | 72 | 77 | 3 | PF00643 | |
| Domain | EPHD | 3.67e-03 | 22 | 77 | 2 | PS51805 | |
| Domain | Peptidase_M12B_ADAM-TS | 4.37e-03 | 24 | 77 | 2 | IPR013273 | |
| Domain | ZF_BBOX | 4.41e-03 | 80 | 77 | 3 | PS50119 | |
| Domain | Znf_B-box | 4.56e-03 | 81 | 77 | 3 | IPR000315 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 26196062 | ||
| Pubmed | TRIM50 protein regulates vesicular trafficking for acid secretion in gastric parietal cells. | 1.22e-08 | 3 | 81 | 3 | 22872646 | |
| Pubmed | 4.96e-08 | 418 | 81 | 10 | 34709266 | ||
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 20049703 | ||
| Pubmed | Williams-Beuren syndrome TRIM50 encodes an E3 ubiquitin ligase. | 1.21e-07 | 5 | 81 | 3 | 18398435 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.35e-07 | 351 | 81 | 9 | 38297188 | |
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 29604308 | ||
| Pubmed | TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization. | 2.42e-07 | 6 | 81 | 3 | 36178239 | |
| Pubmed | 4.23e-07 | 7 | 81 | 3 | 26025256 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8188244 | ||
| Pubmed | DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule. | 5.36e-06 | 2 | 81 | 2 | 17900276 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 32697929 | ||
| Pubmed | Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia. | 5.36e-06 | 2 | 81 | 2 | 38128786 | |
| Pubmed | Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system. | 5.36e-06 | 2 | 81 | 2 | 20022944 | |
| Pubmed | Review: the molecular basis of the Rh blood group phenotypes. | 5.36e-06 | 2 | 81 | 2 | 15373666 | |
| Pubmed | Intron 4 of the RH Gene in Han Chinese, Tibetan, and Mongol Populations. | 5.36e-06 | 2 | 81 | 2 | 26579938 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34968422 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 1898705 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11161244 | ||
| Pubmed | RH diversity in Mali: characterization of a new haplotype RHD*DIVa/RHCE*ceTI(D2). | 5.36e-06 | 2 | 81 | 2 | 25857637 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15685397 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22184011 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22738288 | ||
| Pubmed | Robust expression of SIRT6 inhibits pulpitis via activation of the TRPV1 channel. | 5.36e-06 | 2 | 81 | 2 | 32236974 | |
| Pubmed | Multiple Rh messenger RNA isoforms are produced by alternative splicing. | 5.36e-06 | 2 | 81 | 2 | 1379850 | |
| Pubmed | Characterization of EGFR family gene aberrations in cholangiocarcinoma. | 5.36e-06 | 2 | 81 | 2 | 24927194 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10329015 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22699492 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23772606 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 3135863 | ||
| Pubmed | Sequences and evolution of mammalian RH gene transcripts and proteins. | 5.36e-06 | 2 | 81 | 2 | 9811965 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12393640 | ||
| Pubmed | Molecular genetic basis of the human Rhesus blood group system. | 5.36e-06 | 2 | 81 | 2 | 8220426 | |
| Pubmed | Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism. | 5.36e-06 | 2 | 81 | 2 | 29752658 | |
| Pubmed | Isolation of a new cDNA clone encoding an Rh polypeptide associated with the Rh blood group system. | 5.36e-06 | 2 | 81 | 2 | 7916743 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22690701 | ||
| Pubmed | No Distinction of Orthology/Paralogy between Human and Chimpanzee Rh Blood Group Genes. | 5.36e-06 | 2 | 81 | 2 | 26872772 | |
| Pubmed | RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa. | 5.36e-06 | 2 | 81 | 2 | 22804620 | |
| Pubmed | PGC-1α promotes the growth of ErbB2/Neu-induced mammary tumors by regulating nutrient supply. | 5.36e-06 | 2 | 81 | 2 | 22266114 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 7789951 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 21255571 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11724987 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10627438 | ||
| Pubmed | Polymorphisms in the promoter regions of RHD and RHCE genes in the Chinese Han population. | 5.36e-06 | 2 | 81 | 2 | 37823181 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 30089826 | ||
| Pubmed | Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia. | 5.36e-06 | 2 | 81 | 2 | 29193104 | |
| Pubmed | C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. | 5.36e-06 | 2 | 81 | 2 | 24357318 | |
| Pubmed | RHCE variants inherited with altered RHD alleles in Brazilian blood donors. | 5.36e-06 | 2 | 81 | 2 | 27111588 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8822955 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8808597 | ||
| Pubmed | Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. | 5.36e-06 | 2 | 81 | 2 | 12201845 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19244516 | ||
| Pubmed | Variant RH alleles and Rh immunisation in patients with sickle cell disease. | 5.36e-06 | 2 | 81 | 2 | 24960646 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 30418133 | ||
| Pubmed | A convenient qualitative and quantitative method to investigate RHD-RHCE hybrid genes. | 5.36e-06 | 2 | 81 | 2 | 23550903 | |
| Pubmed | [Expression and significance of HER-2/neu mRNA and RECK mRNA in breast carcinoma tissue]. | 5.36e-06 | 2 | 81 | 2 | 23189844 | |
| Pubmed | Molecular cloning and primary structure of the human blood group RhD polypeptide. | 5.36e-06 | 2 | 81 | 2 | 1438298 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34327661 | ||
| Pubmed | Molecular background of D(C)(e) haplotypes within the white population. | 5.36e-06 | 2 | 81 | 2 | 12084172 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10924335 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12857961 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20233350 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8900235 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 35567753 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 14522988 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23742316 | ||
| Pubmed | A comprehensive survey of both RHD and RHCE allele frequencies in sub-Saharan Africa. | 5.36e-06 | 2 | 81 | 2 | 24033223 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 31324746 | ||
| Pubmed | 6.67e-06 | 16 | 81 | 3 | 22792322 | ||
| Pubmed | ERBB2 ERBB4 GLI3 SUPT7L NFRKB CIZ1 PER1 FMN2 CHD8 ZC3H3 RAI1 KNL1 | 1.03e-05 | 1116 | 81 | 12 | 31753913 | |
| Pubmed | Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin. | 1.60e-05 | 3 | 81 | 2 | 22184199 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 23354620 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 12532415 | ||
| Pubmed | Evolutionary history of the Rh blood group-related genes in vertebrates. | 1.60e-05 | 3 | 81 | 2 | 10970100 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 9851845 | ||
| Pubmed | Conserved evolution of the Rh50 gene compared to its homologous Rh blood group gene. | 1.60e-05 | 3 | 81 | 2 | 9705835 | |
| Pubmed | Hippocampal gene expression induced by cold swim stress depends on sex and handling. | 1.60e-05 | 3 | 81 | 2 | 25459888 | |
| Pubmed | FGF13 Selectively Regulates Heat Nociception by Interacting with Nav1.7. | 1.60e-05 | 3 | 81 | 2 | 28162808 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 31285762 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 10918572 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 19370475 | ||
| Pubmed | Expression and significance of HER family receptors in neuroblastic tumors. | 1.60e-05 | 3 | 81 | 2 | 21203803 | |
| Pubmed | The members of the RH gene family (RH50 and RH30) followed different evolutionary pathways. | 1.60e-05 | 3 | 81 | 2 | 9929383 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 3146980 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 10822899 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 28653892 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 19807729 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 11891317 | ||
| Pubmed | Hydrophobic cluster analysis and modeling of the human Rh protein three-dimensional structures. | 1.60e-05 | 3 | 81 | 2 | 16584906 | |
| Pubmed | Involvement of the neuregulins and their receptors in cardiac and neural development. | 1.60e-05 | 3 | 81 | 2 | 8967893 | |
| Pubmed | ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma. | 1.60e-05 | 3 | 81 | 2 | 23333248 | |
| Pubmed | Expression and potential role of ErbB receptors in type II endometrial cancer. | 1.60e-05 | 3 | 81 | 2 | 23395558 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 28065942 | ||
| Pubmed | Synapses form in skeletal muscles lacking neuregulin receptors. | 1.60e-05 | 3 | 81 | 2 | 15976301 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 24862237 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 15026342 | ||
| Pubmed | TRPV1 and TRPA1 stimulation induces MUC5B secretion in the human nasal airway in vivo. | 1.60e-05 | 3 | 81 | 2 | 21981454 | |
| Pubmed | Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. | 1.60e-05 | 3 | 81 | 2 | 10839362 | |
| Pubmed | Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival. | 1.60e-05 | 3 | 81 | 2 | 25731189 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 23100016 | ||
| Interaction | TTC23 interactions | 9.83e-08 | 208 | 77 | 9 | int:TTC23 | |
| Interaction | USP2 interactions | 3.19e-07 | 239 | 77 | 9 | int:USP2 | |
| Interaction | KDM1A interactions | ZNF462 COL6A1 GRIPAP1 MYH9 KMT2D AHNAK NUP88 GEMIN4 CHD8 BAIAP2 SIRT6 BIRC6 IMMT KNL1 ZNF71 | 2.28e-06 | 941 | 77 | 15 | int:KDM1A |
| Interaction | LYPD6B interactions | 1.46e-05 | 39 | 77 | 4 | int:LYPD6B | |
| Interaction | PHF21A interactions | 4.92e-05 | 343 | 77 | 8 | int:PHF21A | |
| Interaction | NCK2 interactions | 6.42e-05 | 262 | 77 | 7 | int:NCK2 | |
| Interaction | ARL15 interactions | 7.26e-05 | 113 | 77 | 5 | int:ARL15 | |
| Interaction | KLHL40 interactions | 7.64e-05 | 59 | 77 | 4 | int:KLHL40 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.79e-04 | 346 | 81 | 5 | chr17p13 | |
| Cytoband | 7q11.23 | 6.92e-04 | 97 | 81 | 3 | 7q11.23 | |
| Cytoband | 11q12.2 | 2.18e-03 | 39 | 81 | 2 | 11q12.2 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 6.04e-05 | 4 | 58 | 2 | 1096 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius-36|World / Primary Cells by Cluster | 1.52e-06 | 195 | 81 | 6 | bc76a0586cc78f013cb96a2444e63e3c5daa3bc7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius|World / Primary Cells by Cluster | 1.52e-06 | 195 | 81 | 6 | 424d8e2bc7f7e68f74219de06dbbb671c8b4c24c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-06 | 199 | 81 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.18e-06 | 137 | 81 | 5 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.36e-06 | 63 | 81 | 4 | 83e1c91f830aadaf13e13254ce30189fd434bcc9 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendroyte.Trf.Il33_(Il33)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.36e-06 | 63 | 81 | 4 | f2532b1aa117eea550f0ae0b599780c4fe621407 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.36e-06 | 63 | 81 | 4 | 0643435edf3280daf38c950e5bec287a9d5cb517 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendroyte.Trf.Il33_(Il33)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.36e-06 | 63 | 81 | 4 | 71c3afda6534401320791b714e3e2fe83094c914 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.39e-05 | 168 | 81 | 5 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.43e-05 | 169 | 81 | 5 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.79e-05 | 177 | 81 | 5 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.79e-05 | 177 | 81 | 5 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 184 | 81 | 5 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 185 | 81 | 5 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 190 | 81 | 5 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.58e-05 | 191 | 81 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.85e-05 | 195 | 81 | 5 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | kidney_cells-Adult_normal_reference|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 196 | 81 | 5 | 902965bfc5726ca0f1f0a1f6fe3f6d701cc91e6b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.92e-05 | 196 | 81 | 5 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.99e-05 | 197 | 81 | 5 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.99e-05 | 197 | 81 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.07e-05 | 198 | 81 | 5 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.07e-05 | 198 | 81 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.14e-05 | 199 | 81 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.22e-05 | 200 | 81 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 137 | 81 | 4 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 137 | 81 | 4 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pax5_(SN/VTA_(SNr))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 53 | 81 | 3 | ef2fa0364d7807cec2c0a45f940837cac6d22e43 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pax5_(SN/VTA_(SNr))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 53 | 81 | 3 | 974757404e411d7a0d762d21db07f9632a838be3 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pax5_(SN/VTA_(SNr))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 53 | 81 | 3 | ad3eac1ffca39ace1ea1284441c60fe55b1a8470 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 144 | 81 | 4 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.50e-04 | 147 | 81 | 4 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 151 | 81 | 4 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.70e-04 | 152 | 81 | 4 | 00d5503d462cfa009fb4cac79ecee11725a18b9a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.02e-04 | 159 | 81 | 4 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.02e-04 | 159 | 81 | 4 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-04 | 161 | 81 | 4 | 7c9d4410d7142a5f3a05418c994f69978c9ffa17 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 163 | 81 | 4 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.55e-04 | 169 | 81 | 4 | 41cb92b0558f0d5a3e511058efd9110258b88ee3 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.55e-04 | 169 | 81 | 4 | 91f4b6a14708e701b2af22989004282041777491 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 169 | 81 | 4 | 8028622ff362d70d1002e65a74ade46ea7f1f13f | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Megakaryocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.55e-04 | 169 | 81 | 4 | d571e84e01e3316748d4407ed98881b17484e035 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Megakaryocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.61e-04 | 170 | 81 | 4 | eace4dd09cdbde0fa40a6aa0f3dba1114d0ce475 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.79e-04 | 173 | 81 | 4 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.85e-04 | 174 | 81 | 4 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.91e-04 | 175 | 81 | 4 | c33317d8d60ea88ec326daf91dfd3416a62f9938 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-GABAergic_neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.91e-04 | 175 | 81 | 4 | d4ff1f197ad4086286e86817cbff24fa718293fc | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 175 | 81 | 4 | 31f0fb2e47e357dbf9c15436b7df85b3c370ded7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.98e-04 | 176 | 81 | 4 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-04 | 177 | 81 | 4 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 178 | 81 | 4 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-04 | 178 | 81 | 4 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.11e-04 | 178 | 81 | 4 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-04 | 179 | 81 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-04 | 179 | 81 | 4 | 362c003503190dc272fa89185a83a65e063d7a67 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 3.17e-04 | 179 | 81 | 4 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 179 | 81 | 4 | d0fa700648db8ce76a8aa689879a25048299fa40 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-04 | 179 | 81 | 4 | e0eec8d48868c76c3e879f219357c62ceff1bc76 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-04 | 179 | 81 | 4 | 7d2e6bde00a9ab4cb21bd48b140ce205e36f9d77 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 179 | 81 | 4 | 2e49b215b71438400aebb483f2c2c08d5e956961 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.24e-04 | 180 | 81 | 4 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-04 | 180 | 81 | 4 | eee71184ebed2694d3e60f579a44b3cf7dd2cd35 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-04 | 180 | 81 | 4 | a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-04 | 180 | 81 | 4 | 38490017dd590e3fcfa7e88d8d15235d55f90cf1 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.24e-04 | 180 | 81 | 4 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.24e-04 | 180 | 81 | 4 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-04 | 181 | 81 | 4 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.32e-04 | 74 | 81 | 3 | ef4c9eafc794c7d50aef28b37d21b52d3c511499 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.32e-04 | 74 | 81 | 3 | 6ecbdf4186039a031410e09ecd5afa66b6d5e2dc | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-04 | 182 | 81 | 4 | 751bd3e3b49de961523e98197688a05c998c121a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 183 | 81 | 4 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 183 | 81 | 4 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.45e-04 | 183 | 81 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 184 | 81 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.52e-04 | 184 | 81 | 4 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-04 | 185 | 81 | 4 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.60e-04 | 185 | 81 | 4 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-04 | 185 | 81 | 4 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.60e-04 | 185 | 81 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.60e-04 | 185 | 81 | 4 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.60e-04 | 185 | 81 | 4 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 185 | 81 | 4 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-04 | 185 | 81 | 4 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 185 | 81 | 4 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.60e-04 | 185 | 81 | 4 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.60e-04 | 185 | 81 | 4 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.60e-04 | 185 | 81 | 4 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.80e-06 | 195 | 78 | 7 | 5070_DN | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; PC3; HT_HG-U133A | 5.30e-06 | 198 | 78 | 7 | 4609_DN | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; PC3; HT_HG-U133A | 5.66e-06 | 200 | 78 | 7 | 4677_UP | |
| Disease | Anemia, Hemolytic, Congenital | 6.72e-06 | 2 | 77 | 2 | C0002881 | |
| Disease | Rh Deficiency Syndrome | 2.01e-05 | 3 | 77 | 2 | C0272052 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 2.01e-05 | 3 | 77 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | Rh-Null, Regulator Type | 2.01e-05 | 3 | 77 | 2 | C1849387 | |
| Disease | Schizophrenia | CHL1 PPARGC1A ERBB4 CYFIP1 NTNG1 ADAMTSL3 ITGB3 RAI1 RHD GSTA1 | 9.80e-05 | 883 | 77 | 10 | C0036341 |
| Disease | occupational attainment | 1.82e-04 | 42 | 77 | 3 | EFO_0020977 | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 1.86e-04 | 8 | 77 | 2 | DOID:5520 (is_marker_for) | |
| Disease | body fat percentage | 2.87e-04 | 488 | 77 | 7 | EFO_0007800 | |
| Disease | cognitive decline measurement, memory performance, language measurement | 3.64e-04 | 11 | 77 | 2 | EFO_0004874, EFO_0007710, EFO_0007797 | |
| Disease | gallbladder neoplasm | 3.64e-04 | 11 | 77 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 3.64e-04 | 11 | 77 | 2 | C0153452 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 4.11e-04 | 239 | 77 | 5 | EFO_0010934 | |
| Disease | median neuropathy (biomarker_via_orthology) | 5.99e-04 | 14 | 77 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 6.06e-04 | 63 | 77 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | attention deficit hyperactivity disorder, schizophrenia | 6.35e-04 | 64 | 77 | 3 | EFO_0003888, MONDO_0005090 | |
| Disease | autism spectrum disorder (is_implicated_in) | 7.88e-04 | 16 | 77 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 1.12e-03 | 19 | 77 | 2 | DOID:2876 (is_marker_for) | |
| Disease | Hemorrhage | 1.24e-03 | 20 | 77 | 2 | C0019080 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 1.24e-03 | 20 | 77 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | linoleic acid measurement | 1.45e-03 | 186 | 77 | 4 | EFO_0006807 | |
| Disease | Autism Spectrum Disorders | 1.45e-03 | 85 | 77 | 3 | C1510586 | |
| Disease | thalamus volume | 1.45e-03 | 85 | 77 | 3 | EFO_0006935 | |
| Disease | stomach carcinoma (is_marker_for) | 1.79e-03 | 24 | 77 | 2 | DOID:5517 (is_marker_for) | |
| Disease | thrombocytopenia (is_implicated_in) | 2.26e-03 | 27 | 77 | 2 | DOID:1588 (is_implicated_in) | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 2.43e-03 | 28 | 77 | 2 | DOID:12236 (biomarker_via_orthology) | |
| Disease | Mental deterioration | 2.61e-03 | 29 | 77 | 2 | HP_0001268 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKGERLPQPPICTID | 936 | P04626 | |
| DLLEKGERLPQPPIC | 931 | Q15303 | |
| LEDRLALCQPPGPEL | 1906 | Q9HCK8 | |
| CKELPEPNLLPGQLS | 1091 | Q9P2K9 | |
| EELLKLPCPEGLDPD | 4806 | Q9NR09 | |
| KPECVQELELELEGP | 311 | Q2NKJ3 | |
| LEEPLAVPEELCPGL | 361 | Q9H175 | |
| PDVELECPDAKLKGP | 1961 | Q09666 | |
| PDVELECPDAKLKGP | 2156 | Q09666 | |
| LCLDDPPAKDIIDFP | 446 | Q9UKP4 | |
| KLDGPTEQCPDPLPL | 236 | Q9HC84 | |
| PGEPEALPDSLQLDK | 661 | Q7Z5J4 | |
| LIEGCKTQPLPQDPL | 246 | O95980 | |
| DLGEMILLLPVCPPE | 101 | P08263 | |
| PILDGKLEPCPEVDV | 656 | O60890 | |
| LLEELPLPDQQPCIE | 16 | Q7L576 | |
| LEQPCPEGSKTDLPI | 1146 | P10071 | |
| EPLEDLKPCLGINEI | 361 | Q6P4R8 | |
| LEVEEGDPIVLPCNP | 141 | O00533 | |
| GLVCEPPQPEEEELR | 211 | Q5TGJ6 | |
| RPACKIPDDLGFPEE | 201 | P01100 | |
| ELTLDPACQPKLPLD | 11 | Q93015 | |
| CVPAKPPLAEFEEGL | 481 | Q15742 | |
| EELLPLPENVLAPCE | 411 | A9Z1Z3 | |
| KALPCQSPDPELEAG | 586 | O15534 | |
| PLPPSVDDNIKECPL | 291 | E9PQR5 | |
| VDDNIKECPLAPLPP | 296 | E9PQR5 | |
| PPPELCPEDINTFKL | 676 | Q16891 | |
| AKEPCLHPLEPDEVE | 31 | Q9UIQ6 | |
| GQPLSAPCPLLEKEE | 1381 | Q8NG31 | |
| LDLQPCIDLIEKPAG | 506 | P35579 | |
| LLEELPLPDQQPCIE | 16 | Q96F07 | |
| KEIILFPPCEDPARG | 96 | Q8NDY4 | |
| AVAAEPLPPKELCLG | 126 | Q9NQX0 | |
| ALVGEDQPLCPDLPE | 21 | Q9UBK2 | |
| DQPLCPDLPELDLSE | 26 | Q9UBK2 | |
| EDEPILPEIPKCDAN | 611 | Q3MJ16 | |
| QGPPGPDECEILDII | 586 | P12109 | |
| PPEELEDGVCKLPLN | 511 | O75912 | |
| PLEKTELPEGAPELA | 631 | P42701 | |
| PGKPALPPEECAQEE | 1001 | O15021 | |
| LELEEEDPGPFPKLI | 61 | Q8IXH8 | |
| YVVEEPECPKGPDIL | 706 | P05106 | |
| ELELIEGQAKCPPLD | 466 | P22680 | |
| VRLSKECVGPPDPDL | 821 | Q4V328 | |
| GKEQCLFPLPEPQDL | 1551 | Q9NZ56 | |
| PLPPSVDDNIKECPL | 291 | E9PJ23 | |
| VDDNIKECPLAPLPP | 296 | E9PJ23 | |
| EAGKCQLLPLEEPEP | 771 | P80192 | |
| LLEGEDCKLPPQPCA | 396 | O76013 | |
| EKDIAPPPEECLQLL | 551 | Q99567 | |
| LKVKLDPPDITCGDP | 61 | Q9Y2I2 | |
| EPCLPGEECKVLPDL | 101 | Q7Z5A8 | |
| GDEDIKIPENPLEPL | 1586 | Q9C093 | |
| PLSCEAEKQPELELP | 1896 | O60522 | |
| KPVPQLDLPTEPLDC | 356 | Q8IYX7 | |
| QPICLPDSDDKVEPG | 156 | Q7RTY7 | |
| EPKIPGDLDQEPSLL | 196 | O95866 | |
| DGLLAPILNSKPPDC | 1701 | Q15858 | |
| LPDDLLPLDCKNPNA | 111 | O94864 | |
| EPLTDCLKDVDLIPP | 436 | Q9BVR0 | |
| GKCGLPEIFDPPEEL | 16 | Q8N6T7 | |
| GNLLDKDDLAIPPPD | 456 | Q9UQB8 | |
| PEGPCEEPLQLRKLQ | 896 | Q96P48 | |
| VCPEKQDVRDLPGLP | 761 | Q9H2X0 | |
| PEDQDLPPCPEDIAK | 226 | Q9ULV3 | |
| EALRLPGDPEPKVCV | 76 | Q86UV6 | |
| PECKAGEEQPKVLAP | 141 | Q8NHH1 | |
| EDPLLVCQKEPGKPR | 186 | Q8IXZ2 | |
| CLPKPLPEGTEDKDQ | 186 | Q02161 | |
| CLPKPLPKGTEDNDQ | 186 | P18577 | |
| LQKDTCPDPLDGDPN | 16 | Q8NER1 | |
| LDLGDLEEPQPVPKA | 221 | Q9H6E5 | |
| EPELGVKTPEEGCLL | 1116 | Q9P2J2 | |
| EAGCVPLLHPEEIKP | 21 | Q8IUH5 | |
| VPEEGPKDLRCPLCL | 2246 | Q96JM2 | |
| EALRLPGDPEPKVCV | 76 | Q86UV7 | |
| ILSDEDKPLFGPLPC | 1346 | Q8IWV8 | |
| EALRLPGDPEPKVCV | 76 | Q86XT4 | |
| CVLVPPRLDDPTEKG | 86 | Q9NQZ8 | |
| ELEEFLCPVKTPPGL | 176 | Q9BYX2 | |
| DTELPEEPCLPQKEP | 331 | Q9H0D2 | |
| ETELPEEECEGPKLP | 601 | P82987 | |
| KPQGIPVAALLEPDE | 636 | P57678 | |
| PNPLALEAGKLPCED | 2976 | O14686 |